Latest Analysis

1,840 tickers · updated regularly
Ranks this page's recent reports by score.
The Mosaic Company
MOS·Materials
D ★Strong Sell
Current$22.33
Nov 6, 2026

Mosaic's globally significant phosphate and potash assets offer cyclical recovery potential, but persistent phosphate losses, negative free cash flow, and elevated leverage make the near-term investment case unattractive.

Score
51
PACS Group, Inc.
PACS·Healthcare
C ★★Sell
Current$50.20
Nov 6, 2026

PACS offers strong skilled nursing growth, superior occupancy, and improving cash generation, but unresolved accounting controls, reimbursement investigations, and acquisition-related risks undermine investment confidence.

Score
59
Super Group (SGHC) Limited
SGHC·Consumer Discretionary
A ★★★★Buy
Current$11.56
Target$15.75
Return+36.2%
Nov 6, 2026

Super Group combines profitable online casino growth, strong cash generation, and attractive shareholder returns at a moderate valuation, although gambling regulation, weak customer switching costs, and sportsbook volatility remain important risks.

Score
84
SM Energy Company
SM·Energy
B ★★★Hold
Current$29.63
Target$40.00
Return+35.0%
Nov 6, 2026

SM Energy combines improving merger synergies, substantial free cash flow, and discounted valuation with meaningful upside potential, but commodity cyclicality, financial leverage, and production execution remain critical risks.

Score
73
Jackson Financial Inc.
JXN·Financials
B ★★★Hold
Current$132.73
Target$145.00
Return+9.2%
Nov 6, 2026

Jackson Financial combines record annuity sales, strong regulatory capital, and substantial shareholder returns with a low normalized earnings multiple, but volatile insurance guarantees and an elevated historical P/B valuation limit its margin of safety.

Score
71
Gartner, Inc.
IT·Technology
A ★★★★Buy
Current$198.07
Target$247.50
Return+25.0%
Nov 6, 2026

Gartner combines a durable enterprise research franchise and strong free cash flow with a discounted valuation, although slowing contract growth and AI-driven substitution threaten the sustainability of its historical premium.

Score
82
Henry Schein, Inc.
HSIC·Healthcare
A ★★★★Buy
Current$85.31
Target$98.60
Return+15.6%
Nov 6, 2026

Henry Schein offers a healthcare distribution earnings-recovery opportunity supported by share gains, margin expansion, and buybacks, although elevated leverage and modest returns on invested capital constrain its upside.

Score
75
Sunoco LP
SUN·Energy
A ★★★★Buy
Current$61.72
Target$74.09
Return+20.0%
Nov 6, 2026

Sunoco offers attractive income and distribution growth backed by an expanded global fuel and infrastructure network, although acquisition integration, substantial debt, and refining-margin volatility could weaken cash-flow resilience.

Score
79
Mirum Pharmaceuticals, Inc.
MIRM·Healthcare
B ★★★Hold
Current$93.54
Target$104.00
Return+11.2%
Nov 6, 2026

Mirum's expanding rare-disease drug portfolio and late-stage pipeline support sustained commercial growth, but substantial dilution, negative recent cash flow, and demanding valuation limit near-term investment appeal.

Score
65
Duolingo, Inc.
DUOL·Technology
B ★★★Hold
Current$157.02
Target$176.97
Return+12.7%
Nov 6, 2026

Duolingo combines a leading global learning platform, accelerating user engagement, and strong recurring cash flow, but premium operating-earnings valuation and uncertain subscriber monetization constrain near-term upside.

Score
74
American Financial Group, Inc.
AFG·Financials
A ★★★★Buy
Current$156.35
Target$163.49
Return+4.6%
Nov 6, 2026

American Financial Group combines strong specialty underwriting, high ROE and shareholder-friendly capital returns at a reasonable valuation, but insurance-cycle volatility and nonrecurring investment gains limit near-term upside.

Score
77